0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Huntington Disease Protein Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-12P9534
Home | Market Reports | Health| Pharmacy
Global Huntington Disease Protein Market Insights and Forecast to 2028
BUY CHAPTERS

Global Huntington Disease Protein Market Research Report 2025

Code: QYRE-Auto-12P9534
Report
September 2025
Pages:82
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Huntington Disease Protein Market

The global market for Huntington Disease Protein was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Huntington Disease Protein is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Huntington Disease Protein is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Huntington Disease Protein include AFFiRiS AG, Ionis Pharmaceuticals, Inc., Neurimmune Holding AG, nLife Therapeutics, S.L., reMYND NV, Sangamo BioSciences, Inc., UniQure N.V., Voyager Therapeutics, Inc., Vybion, Inc., WAVE Life Sciences Ltd., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Huntington Disease Protein, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Huntington Disease Protein.
The Huntington Disease Protein market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Huntington Disease Protein market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Huntington Disease Protein manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Huntington Disease Protein Market Report

Report Metric Details
Report Name Huntington Disease Protein Market
Segment by Type
  • NI-302
  • NLF-HD
  • P-301905
  • IONIS-HTTRx
  • Others
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company AFFiRiS AG, Ionis Pharmaceuticals, Inc., Neurimmune Holding AG, nLife Therapeutics, S.L., reMYND NV, Sangamo BioSciences, Inc., UniQure N.V., Voyager Therapeutics, Inc., Vybion, Inc., WAVE Life Sciences Ltd.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Huntington Disease Protein manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Huntington Disease Protein in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Huntington Disease Protein Market report?

Ans: The main players in the Huntington Disease Protein Market are AFFiRiS AG, Ionis Pharmaceuticals, Inc., Neurimmune Holding AG, nLife Therapeutics, S.L., reMYND NV, Sangamo BioSciences, Inc., UniQure N.V., Voyager Therapeutics, Inc., Vybion, Inc., WAVE Life Sciences Ltd.

What are the Application segmentation covered in the Huntington Disease Protein Market report?

Ans: The Applications covered in the Huntington Disease Protein Market report are Alzheimer's Disease, Kennedy's Disease, Spinocerebellar Ataxia, Others

What are the Type segmentation covered in the Huntington Disease Protein Market report?

Ans: The Types covered in the Huntington Disease Protein Market report are NI-302, NLF-HD, P-301905, IONIS-HTTRx, Others

Recommended Reports

Protein Technologies

Therapeutic Proteins

Neurodegenerative Disease

1 Huntington Disease Protein Market Overview
1.1 Product Definition
1.2 Huntington Disease Protein by Type
1.2.1 Global Huntington Disease Protein Market Value Comparison by Type (2024 VS 2031)
1.2.2 NI-302
1.2.3 NLF-HD
1.2.4 P-301905
1.2.5 IONIS-HTTRx
1.2.6 Others
1.3 Huntington Disease Protein by Application
1.3.1 Global Huntington Disease Protein Market Value by Application (2024 VS 2031)
1.3.2 Alzheimer's Disease
1.3.3 Kennedy's Disease
1.3.4 Spinocerebellar Ataxia
1.3.5 Others
1.4 Global Huntington Disease Protein Market Size Estimates and Forecasts
1.4.1 Global Huntington Disease Protein Revenue 2020-2031
1.4.2 Global Huntington Disease Protein Sales 2020-2031
1.4.3 Global Huntington Disease Protein Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Huntington Disease Protein Market Competition by Manufacturers
2.1 Global Huntington Disease Protein Sales Market Share by Manufacturers (2020-2025)
2.2 Global Huntington Disease Protein Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Huntington Disease Protein Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Huntington Disease Protein, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Huntington Disease Protein, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Huntington Disease Protein, Product Type & Application
2.7 Global Key Manufacturers of Huntington Disease Protein, Date of Enter into This Industry
2.8 Global Huntington Disease Protein Market Competitive Situation and Trends
2.8.1 Global Huntington Disease Protein Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Huntington Disease Protein Players Market Share by Revenue
2.8.3 Global Huntington Disease Protein Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Huntington Disease Protein Market Scenario by Region
3.1 Global Huntington Disease Protein Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Huntington Disease Protein Sales by Region: 2020-2031
3.2.1 Global Huntington Disease Protein Sales by Region: 2020-2025
3.2.2 Global Huntington Disease Protein Sales by Region: 2026-2031
3.3 Global Huntington Disease Protein Revenue by Region: 2020-2031
3.3.1 Global Huntington Disease Protein Revenue by Region: 2020-2025
3.3.2 Global Huntington Disease Protein Revenue by Region: 2026-2031
3.4 North America Huntington Disease Protein Market Facts & Figures by Country
3.4.1 North America Huntington Disease Protein Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Huntington Disease Protein Sales by Country (2020-2031)
3.4.3 North America Huntington Disease Protein Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Huntington Disease Protein Market Facts & Figures by Country
3.5.1 Europe Huntington Disease Protein Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Huntington Disease Protein Sales by Country (2020-2031)
3.5.3 Europe Huntington Disease Protein Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Huntington Disease Protein Market Facts & Figures by Region
3.6.1 Asia Pacific Huntington Disease Protein Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Huntington Disease Protein Sales by Region (2020-2031)
3.6.3 Asia Pacific Huntington Disease Protein Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Huntington Disease Protein Market Facts & Figures by Country
3.7.1 Latin America Huntington Disease Protein Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Huntington Disease Protein Sales by Country (2020-2031)
3.7.3 Latin America Huntington Disease Protein Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Huntington Disease Protein Market Facts & Figures by Country
3.8.1 Middle East and Africa Huntington Disease Protein Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Huntington Disease Protein Sales by Country (2020-2031)
3.8.3 Middle East and Africa Huntington Disease Protein Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Huntington Disease Protein Sales by Type (2020-2031)
4.1.1 Global Huntington Disease Protein Sales by Type (2020-2025)
4.1.2 Global Huntington Disease Protein Sales by Type (2026-2031)
4.1.3 Global Huntington Disease Protein Sales Market Share by Type (2020-2031)
4.2 Global Huntington Disease Protein Revenue by Type (2020-2031)
4.2.1 Global Huntington Disease Protein Revenue by Type (2020-2025)
4.2.2 Global Huntington Disease Protein Revenue by Type (2026-2031)
4.2.3 Global Huntington Disease Protein Revenue Market Share by Type (2020-2031)
4.3 Global Huntington Disease Protein Price by Type (2020-2031)
5 Segment by Application
5.1 Global Huntington Disease Protein Sales by Application (2020-2031)
5.1.1 Global Huntington Disease Protein Sales by Application (2020-2025)
5.1.2 Global Huntington Disease Protein Sales by Application (2026-2031)
5.1.3 Global Huntington Disease Protein Sales Market Share by Application (2020-2031)
5.2 Global Huntington Disease Protein Revenue by Application (2020-2031)
5.2.1 Global Huntington Disease Protein Revenue by Application (2020-2025)
5.2.2 Global Huntington Disease Protein Revenue by Application (2026-2031)
5.2.3 Global Huntington Disease Protein Revenue Market Share by Application (2020-2031)
5.3 Global Huntington Disease Protein Price by Application (2020-2031)
6 Key Companies Profiled
6.1 AFFiRiS AG
6.1.1 AFFiRiS AG Company Information
6.1.2 AFFiRiS AG Description and Business Overview
6.1.3 AFFiRiS AG Huntington Disease Protein Sales, Revenue and Gross Margin (2020-2025)
6.1.4 AFFiRiS AG Huntington Disease Protein Product Portfolio
6.1.5 AFFiRiS AG Recent Developments/Updates
6.2 Ionis Pharmaceuticals, Inc.
6.2.1 Ionis Pharmaceuticals, Inc. Company Information
6.2.2 Ionis Pharmaceuticals, Inc. Description and Business Overview
6.2.3 Ionis Pharmaceuticals, Inc. Huntington Disease Protein Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Ionis Pharmaceuticals, Inc. Huntington Disease Protein Product Portfolio
6.2.5 Ionis Pharmaceuticals, Inc. Recent Developments/Updates
6.3 Neurimmune Holding AG
6.3.1 Neurimmune Holding AG Company Information
6.3.2 Neurimmune Holding AG Description and Business Overview
6.3.3 Neurimmune Holding AG Huntington Disease Protein Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Neurimmune Holding AG Huntington Disease Protein Product Portfolio
6.3.5 Neurimmune Holding AG Recent Developments/Updates
6.4 nLife Therapeutics, S.L.
6.4.1 nLife Therapeutics, S.L. Company Information
6.4.2 nLife Therapeutics, S.L. Description and Business Overview
6.4.3 nLife Therapeutics, S.L. Huntington Disease Protein Sales, Revenue and Gross Margin (2020-2025)
6.4.4 nLife Therapeutics, S.L. Huntington Disease Protein Product Portfolio
6.4.5 nLife Therapeutics, S.L. Recent Developments/Updates
6.5 reMYND NV
6.5.1 reMYND NV Company Information
6.5.2 reMYND NV Description and Business Overview
6.5.3 reMYND NV Huntington Disease Protein Sales, Revenue and Gross Margin (2020-2025)
6.5.4 reMYND NV Huntington Disease Protein Product Portfolio
6.5.5 reMYND NV Recent Developments/Updates
6.6 Sangamo BioSciences, Inc.
6.6.1 Sangamo BioSciences, Inc. Company Information
6.6.2 Sangamo BioSciences, Inc. Description and Business Overview
6.6.3 Sangamo BioSciences, Inc. Huntington Disease Protein Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Sangamo BioSciences, Inc. Huntington Disease Protein Product Portfolio
6.6.5 Sangamo BioSciences, Inc. Recent Developments/Updates
6.7 UniQure N.V.
6.7.1 UniQure N.V. Company Information
6.7.2 UniQure N.V. Description and Business Overview
6.7.3 UniQure N.V. Huntington Disease Protein Sales, Revenue and Gross Margin (2020-2025)
6.7.4 UniQure N.V. Huntington Disease Protein Product Portfolio
6.7.5 UniQure N.V. Recent Developments/Updates
6.8 Voyager Therapeutics, Inc.
6.8.1 Voyager Therapeutics, Inc. Company Information
6.8.2 Voyager Therapeutics, Inc. Description and Business Overview
6.8.3 Voyager Therapeutics, Inc. Huntington Disease Protein Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Voyager Therapeutics, Inc. Huntington Disease Protein Product Portfolio
6.8.5 Voyager Therapeutics, Inc. Recent Developments/Updates
6.9 Vybion, Inc.
6.9.1 Vybion, Inc. Company Information
6.9.2 Vybion, Inc. Description and Business Overview
6.9.3 Vybion, Inc. Huntington Disease Protein Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Vybion, Inc. Huntington Disease Protein Product Portfolio
6.9.5 Vybion, Inc. Recent Developments/Updates
6.10 WAVE Life Sciences Ltd.
6.10.1 WAVE Life Sciences Ltd. Company Information
6.10.2 WAVE Life Sciences Ltd. Description and Business Overview
6.10.3 WAVE Life Sciences Ltd. Huntington Disease Protein Sales, Revenue and Gross Margin (2020-2025)
6.10.4 WAVE Life Sciences Ltd. Huntington Disease Protein Product Portfolio
6.10.5 WAVE Life Sciences Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Huntington Disease Protein Industry Chain Analysis
7.2 Huntington Disease Protein Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Huntington Disease Protein Production Mode & Process Analysis
7.4 Huntington Disease Protein Sales and Marketing
7.4.1 Huntington Disease Protein Sales Channels
7.4.2 Huntington Disease Protein Distributors
7.5 Huntington Disease Protein Customer Analysis
8 Huntington Disease Protein Market Dynamics
8.1 Huntington Disease Protein Industry Trends
8.2 Huntington Disease Protein Market Drivers
8.3 Huntington Disease Protein Market Challenges
8.4 Huntington Disease Protein Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Huntington Disease Protein Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Huntington Disease Protein Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Huntington Disease Protein Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Huntington Disease Protein Sales (K Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Huntington Disease Protein Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Huntington Disease Protein Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Huntington Disease Protein Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Huntington Disease Protein Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Huntington Disease Protein, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Huntington Disease Protein, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Huntington Disease Protein, Product Type & Application
 Table 12. Global Key Manufacturers of Huntington Disease Protein, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Huntington Disease Protein by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Huntington Disease Protein as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Huntington Disease Protein Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Huntington Disease Protein Sales by Region (2020-2025) & (K Pcs)
 Table 18. Global Huntington Disease Protein Sales Market Share by Region (2020-2025)
 Table 19. Global Huntington Disease Protein Sales by Region (2026-2031) & (K Pcs)
 Table 20. Global Huntington Disease Protein Sales Market Share by Region (2026-2031)
 Table 21. Global Huntington Disease Protein Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Huntington Disease Protein Revenue Market Share by Region (2020-2025)
 Table 23. Global Huntington Disease Protein Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Huntington Disease Protein Revenue Market Share by Region (2026-2031)
 Table 25. North America Huntington Disease Protein Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Huntington Disease Protein Sales by Country (2020-2025) & (K Pcs)
 Table 27. North America Huntington Disease Protein Sales by Country (2026-2031) & (K Pcs)
 Table 28. North America Huntington Disease Protein Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Huntington Disease Protein Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Huntington Disease Protein Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Huntington Disease Protein Sales by Country (2020-2025) & (K Pcs)
 Table 32. Europe Huntington Disease Protein Sales by Country (2026-2031) & (K Pcs)
 Table 33. Europe Huntington Disease Protein Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Huntington Disease Protein Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Huntington Disease Protein Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Huntington Disease Protein Sales by Region (2020-2025) & (K Pcs)
 Table 37. Asia Pacific Huntington Disease Protein Sales by Region (2026-2031) & (K Pcs)
 Table 38. Asia Pacific Huntington Disease Protein Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Huntington Disease Protein Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Huntington Disease Protein Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Huntington Disease Protein Sales by Country (2020-2025) & (K Pcs)
 Table 42. Latin America Huntington Disease Protein Sales by Country (2026-2031) & (K Pcs)
 Table 43. Latin America Huntington Disease Protein Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Huntington Disease Protein Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Huntington Disease Protein Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Huntington Disease Protein Sales by Country (2020-2025) & (K Pcs)
 Table 47. Middle East and Africa Huntington Disease Protein Sales by Country (2026-2031) & (K Pcs)
 Table 48. Middle East and Africa Huntington Disease Protein Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Huntington Disease Protein Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Huntington Disease Protein Sales (K Pcs) by Type (2020-2025)
 Table 51. Global Huntington Disease Protein Sales (K Pcs) by Type (2026-2031)
 Table 52. Global Huntington Disease Protein Sales Market Share by Type (2020-2025)
 Table 53. Global Huntington Disease Protein Sales Market Share by Type (2026-2031)
 Table 54. Global Huntington Disease Protein Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Huntington Disease Protein Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Huntington Disease Protein Revenue Market Share by Type (2020-2025)
 Table 57. Global Huntington Disease Protein Revenue Market Share by Type (2026-2031)
 Table 58. Global Huntington Disease Protein Price (USD/Pcs) by Type (2020-2025)
 Table 59. Global Huntington Disease Protein Price (USD/Pcs) by Type (2026-2031)
 Table 60. Global Huntington Disease Protein Sales (K Pcs) by Application (2020-2025)
 Table 61. Global Huntington Disease Protein Sales (K Pcs) by Application (2026-2031)
 Table 62. Global Huntington Disease Protein Sales Market Share by Application (2020-2025)
 Table 63. Global Huntington Disease Protein Sales Market Share by Application (2026-2031)
 Table 64. Global Huntington Disease Protein Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Huntington Disease Protein Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Huntington Disease Protein Revenue Market Share by Application (2020-2025)
 Table 67. Global Huntington Disease Protein Revenue Market Share by Application (2026-2031)
 Table 68. Global Huntington Disease Protein Price (USD/Pcs) by Application (2020-2025)
 Table 69. Global Huntington Disease Protein Price (USD/Pcs) by Application (2026-2031)
 Table 70. AFFiRiS AG Company Information
 Table 71. AFFiRiS AG Description and Business Overview
 Table 72. AFFiRiS AG Huntington Disease Protein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 73. AFFiRiS AG Huntington Disease Protein Product
 Table 74. AFFiRiS AG Recent Developments/Updates
 Table 75. Ionis Pharmaceuticals, Inc. Company Information
 Table 76. Ionis Pharmaceuticals, Inc. Description and Business Overview
 Table 77. Ionis Pharmaceuticals, Inc. Huntington Disease Protein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 78. Ionis Pharmaceuticals, Inc. Huntington Disease Protein Product
 Table 79. Ionis Pharmaceuticals, Inc. Recent Developments/Updates
 Table 80. Neurimmune Holding AG Company Information
 Table 81. Neurimmune Holding AG Description and Business Overview
 Table 82. Neurimmune Holding AG Huntington Disease Protein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 83. Neurimmune Holding AG Huntington Disease Protein Product
 Table 84. Neurimmune Holding AG Recent Developments/Updates
 Table 85. nLife Therapeutics, S.L. Company Information
 Table 86. nLife Therapeutics, S.L. Description and Business Overview
 Table 87. nLife Therapeutics, S.L. Huntington Disease Protein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 88. nLife Therapeutics, S.L. Huntington Disease Protein Product
 Table 89. nLife Therapeutics, S.L. Recent Developments/Updates
 Table 90. reMYND NV Company Information
 Table 91. reMYND NV Description and Business Overview
 Table 92. reMYND NV Huntington Disease Protein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 93. reMYND NV Huntington Disease Protein Product
 Table 94. reMYND NV Recent Developments/Updates
 Table 95. Sangamo BioSciences, Inc. Company Information
 Table 96. Sangamo BioSciences, Inc. Description and Business Overview
 Table 97. Sangamo BioSciences, Inc. Huntington Disease Protein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 98. Sangamo BioSciences, Inc. Huntington Disease Protein Product
 Table 99. Sangamo BioSciences, Inc. Recent Developments/Updates
 Table 100. UniQure N.V. Company Information
 Table 101. UniQure N.V. Description and Business Overview
 Table 102. UniQure N.V. Huntington Disease Protein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 103. UniQure N.V. Huntington Disease Protein Product
 Table 104. UniQure N.V. Recent Developments/Updates
 Table 105. Voyager Therapeutics, Inc. Company Information
 Table 106. Voyager Therapeutics, Inc. Description and Business Overview
 Table 107. Voyager Therapeutics, Inc. Huntington Disease Protein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 108. Voyager Therapeutics, Inc. Huntington Disease Protein Product
 Table 109. Voyager Therapeutics, Inc. Recent Developments/Updates
 Table 110. Vybion, Inc. Company Information
 Table 111. Vybion, Inc. Description and Business Overview
 Table 112. Vybion, Inc. Huntington Disease Protein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 113. Vybion, Inc. Huntington Disease Protein Product
 Table 114. Vybion, Inc. Recent Developments/Updates
 Table 115. WAVE Life Sciences Ltd. Company Information
 Table 116. WAVE Life Sciences Ltd. Description and Business Overview
 Table 117. WAVE Life Sciences Ltd. Huntington Disease Protein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 118. WAVE Life Sciences Ltd. Huntington Disease Protein Product
 Table 119. WAVE Life Sciences Ltd. Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Huntington Disease Protein Distributors List
 Table 123. Huntington Disease Protein Customers List
 Table 124. Huntington Disease Protein Market Trends
 Table 125. Huntington Disease Protein Market Drivers
 Table 126. Huntington Disease Protein Market Challenges
 Table 127. Huntington Disease Protein Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Huntington Disease Protein
 Figure 2. Global Huntington Disease Protein Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Huntington Disease Protein Market Share by Type: 2024 & 2031
 Figure 4. NI-302 Product Picture
 Figure 5. NLF-HD Product Picture
 Figure 6. P-301905 Product Picture
 Figure 7. IONIS-HTTRx Product Picture
 Figure 8. Others Product Picture
 Figure 9. Global Huntington Disease Protein Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global Huntington Disease Protein Market Share by Application: 2024 & 2031
 Figure 11. Alzheimer's Disease
 Figure 12. Kennedy's Disease
 Figure 13. Spinocerebellar Ataxia
 Figure 14. Others
 Figure 15. Global Huntington Disease Protein Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Huntington Disease Protein Market Size (2020-2031) & (US$ Million)
 Figure 17. Global Huntington Disease Protein Sales (2020-2031) & (K Pcs)
 Figure 18. Global Huntington Disease Protein Average Price (USD/Pcs) & (2020-2031)
 Figure 19. Huntington Disease Protein Report Years Considered
 Figure 20. Huntington Disease Protein Sales Share by Manufacturers in 2024
 Figure 21. Global Huntington Disease Protein Revenue Share by Manufacturers in 2024
 Figure 22. Global 5 and 10 Largest Huntington Disease Protein Players: Market Share by Revenue in Huntington Disease Protein in 2024
 Figure 23. Huntington Disease Protein Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 24. Global Huntington Disease Protein Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 25. North America Huntington Disease Protein Sales Market Share by Country (2020-2031)
 Figure 26. North America Huntington Disease Protein Revenue Market Share by Country (2020-2031)
 Figure 27. U.S. Huntington Disease Protein Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Canada Huntington Disease Protein Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Europe Huntington Disease Protein Sales Market Share by Country (2020-2031)
 Figure 30. Europe Huntington Disease Protein Revenue Market Share by Country (2020-2031)
 Figure 31. Germany Huntington Disease Protein Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. France Huntington Disease Protein Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. U.K. Huntington Disease Protein Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Italy Huntington Disease Protein Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Russia Huntington Disease Protein Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Asia Pacific Huntington Disease Protein Sales Market Share by Region (2020-2031)
 Figure 37. Asia Pacific Huntington Disease Protein Revenue Market Share by Region (2020-2031)
 Figure 38. China Huntington Disease Protein Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Japan Huntington Disease Protein Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. South Korea Huntington Disease Protein Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. India Huntington Disease Protein Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Australia Huntington Disease Protein Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Taiwan Huntington Disease Protein Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Indonesia Huntington Disease Protein Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Thailand Huntington Disease Protein Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Malaysia Huntington Disease Protein Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Philippines Huntington Disease Protein Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Latin America Huntington Disease Protein Sales Market Share by Country (2020-2031)
 Figure 49. Latin America Huntington Disease Protein Revenue Market Share by Country (2020-2031)
 Figure 50. Mexico Huntington Disease Protein Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Brazil Huntington Disease Protein Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Argentina Huntington Disease Protein Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Middle East and Africa Huntington Disease Protein Sales Market Share by Country (2020-2031)
 Figure 54. Middle East and Africa Huntington Disease Protein Revenue Market Share by Country (2020-2031)
 Figure 55. Turkey Huntington Disease Protein Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Saudi Arabia Huntington Disease Protein Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. UAE Huntington Disease Protein Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. Global Sales Market Share of Huntington Disease Protein by Type (2020-2031)
 Figure 59. Global Revenue Market Share of Huntington Disease Protein by Type (2020-2031)
 Figure 60. Global Huntington Disease Protein Price (USD/Pcs) by Type (2020-2031)
 Figure 61. Global Sales Market Share of Huntington Disease Protein by Application (2020-2031)
 Figure 62. Global Revenue Market Share of Huntington Disease Protein by Application (2020-2031)
 Figure 63. Global Huntington Disease Protein Price (USD/Pcs) by Application (2020-2031)
 Figure 64. Huntington Disease Protein Value Chain
 Figure 65. Channels of Distribution (Direct Vs Distribution)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart